George Avgerinos
Corporate Officer/Principal bei FORTRESS BIOTECH, INC.
Vermögen: 87 356 $ am 31.03.2024
Profil
George C.
Avgerinos is a professional with a doctorate degree from Massachusetts Institute of Technology and an undergraduate degree from the University of Connecticut.
He is currently the Senior Vice President-Biologics Operations at Fortress Biotech, Inc. Prior to this, he was the Vice President at AbbVie, Inc. from 2008 to 2013 and the Chief Operating Officer & Secretary at Origo Acquisition Corp.
from 2014 to 2016.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
FORTRESS BIOTECH, INC.
0,24% | 27.03.2024 | 43 678 ( 0,24% ) | 87 356 $ | 31.03.2024 |
Aktive Positionen von George Avgerinos
Unternehmen | Position | Beginn |
---|---|---|
FORTRESS BIOTECH, INC. | Corporate Officer/Principal | 04.06.2013 |
Ehemalige bekannte Positionen von George Avgerinos
Unternehmen | Position | Ende |
---|---|---|
ORIGO ACQUISITION CORP | Chief Operating Officer | 10.06.2016 |
ABBVIE INC. | Corporate Officer/Principal | 01.07.2013 |
Ausbildung von George Avgerinos
Massachusetts Institute of Technology | Doctorate Degree |
University of Connecticut | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
FORTRESS BIOTECH, INC. | Health Technology |
ABBVIE INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Origo Acquisition Corp.
Origo Acquisition Corp. Financial ConglomeratesFinance Origo Acquisition Corp. is a blank check company. It seeks to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The company was founded on August 26, 2014 and is headquartered in New York, NY. | Finance |